CDT Equity shares are trading higher after the company announced that the patent covering the use of AZD5904 in male infertility has been granted in Canada.

Benzinga Newsdesk www.benzinga.com Positive 94.6%

Neg 0% Neu 0% Pos 94.6%

Comments

No comments yet. Be the first!